NGVT Ingevity Corp
company
SEC Filings & Insider Trading Activity 2026

CIK: 1653477
Health Care
Chemicals & Allied Products 48 filings
Russell 2000

Latest Ingevity Corp (NGVT) SEC EDGAR filings in 2026 — including the most recent 10-K annual report filed on February 26, 2026, a 10-Q quarterly report filed on November 6, 2025, an 8-K current report filed on April 15, 2026. SignalX aggregates every new 10-K annual report, 10-Q quarterly report, 8-K current report, and Form 4 insider transaction for Ingevity Corp (NGVT) (SEC CIK 1653477), with AI-powered section-by-section summaries updated daily.

10-Q: 30
10-K: 10
8-K: 8

Latest 2026 SEC Filing Dates

10-K Annual Report
Feb 26, 2026
10-Q Quarterly Report
Nov 6, 2025
8-K Current Report
Apr 15, 2026

AI 10-K Annual Report Analysis
Latest 10-K (2025-12-31)

Business Overview

  • Core business: Specialty chemicals and materials manufacturing, focusing on automotive carbon, pavement, and road marking technologies
  • Legal expense accrual of $95.4M for patent infringement judgment against BASF, final appeal lost in Feb 2026, impacting financials and cash flow
+3 more insights

Risk Factors

  • Regulatory risk: EU GDPR, CCPA, and China Cybersecurity Law impose complex data privacy compliance and significant fines for violations
  • Geopolitical risk: 43% sales outside US exposed to tariffs and retaliatory measures by China harming Performance Materials and Chemicals margins
+3 more insights

AI 10-Q Quarterly Report Analysis
Latest 10-Q (2025-09-30)

Risk Factors

  • Newly added trade policy risk from new U.S. tariffs and Chinese retaliatory measures lowering margins on products sold into China
  • Materially updated operational risk of facility disruptions, including labor strikes with recent CBA expirations and renewals through mid-2025
Read full Q3 2025 10-Q analysis →

AI 8-K Current Report Analysis
Recent 8-K Filings

Filed Feb 25, 2026
8-K
Full analysis →

Item 7.01: Regulation FD Disclosure

  • Starting 2025 Form 10-K, corporate overhead costs removed from segment results to show cleaner segment-level profitability
  • Affected costs include executive office, finance, legal, HR, and NYSE compliance expenses — previously obscuring true segment margins

Item 2.02: Results of Operations and Financial Condition

  • Q4 and full-year 2025 preliminary financial results announced Feb 25, 2026
  • Key figures in Exhibit 99.1 — review press release for revenue, earnings, and margin detail

Annual Reports Archive
10-K

AI-powered analysis of Ingevity Corp (NGVT) 10-K annual reports filed with SEC EDGAR.

Quarterly Reports Archive
10-Q

AI-powered analysis of Ingevity Corp (NGVT) 10-Q quarterly reports filed with SEC EDGAR.

Recent 8-K Filings
Current Reports

AI-powered analysis of Ingevity Corp (NGVT) 8-K current reports disclosing material events.

Financial Summary
XBRL

FY2022FY2023FY2024FY2025
Profitability
Revenue$1.7B$1.7B$1.4B$1.2B
Gross Profit$570.1M$471.9M$454.7M$461.5M
Operating Income$396.8M$369.0M$418.7M
Net Income-$5.4M-$430.3M-$167.1M
Gross Margin34.2%27.9%32.3%39.5%
Op. Margin23.5%26.2%35.9%
Net Margin-0.3%-30.6%-14.3%
Balance Sheet
Total Assets$2.6B$2.0B$1.7B
Equity$631.4M$195.2M$29.7M
ROE-0.9%-220.4%-562.6%

Source: XBRL financial data from Ingevity Corp (NGVT) 10-K filings on SEC EDGAR. All figures in USD. Key metrics include revenue, net income, gross profit, gross profit margin, operating income, EPS (diluted), total assets, stockholders' equity, return on equity (ROE), operating cash flow, and capital expenditure.

Latest 2026 SEC Filings — 10-K, 10-Q, 8-K & Form 4

FormFiling DatePeriodAnalysisSEC
8-K
Apr 15, 2026
8-K
Mar 30, 2026
10-K
Feb 26, 2026Dec 31, 2025Analysis
8-K
Feb 25, 2026Analysis
8-K
Feb 23, 2026Analysis
8-K
Jan 5, 2026
8-K
Dec 8, 2025
8-K
Dec 8, 2025
8-K
Dec 1, 2025
10-Q
Nov 6, 2025Sep 30, 2025Analysis
10-Q
Aug 5, 2025Jun 30, 2025
10-Q
May 6, 2025Mar 31, 2025
10-K
Feb 19, 2025Dec 31, 2024
10-Q
Oct 30, 2024Sep 30, 2024
10-Q
Aug 1, 2024Jun 30, 2024
10-Q
May 2, 2024Mar 31, 2024
10-K
Feb 22, 2024Dec 31, 2023
10-Q
Nov 2, 2023Sep 30, 2023
10-Q
Aug 3, 2023Jun 30, 2023
10-Q
May 4, 2023Mar 31, 2023
10-K
Feb 28, 2023Dec 31, 2022
10-Q
Nov 3, 2022Sep 30, 2022
10-Q
Aug 3, 2022Jun 30, 2022
10-Q
May 5, 2022Mar 31, 2022
10-K
Feb 24, 2022Dec 31, 2021

Frequently Asked Questions

What are the latest NGVT SEC filings in 2026?

Ingevity Corp (NGVT) has filed a 10-K annual report on February 26, 2026, a 10-Q quarterly report on November 6, 2025, an 8-K current report on April 15, 2026 with the SEC. SignalX tracks every new SEC EDGAR filing daily, including 10-K, 10-Q, 8-K, and Form 4 insider transactions, with AI-powered summaries of key sections.

When did NGVT file its most recent 10-K annual report?

Ingevity Corp (NGVT) filed its most recent 10-K annual report on February 26, 2026. The 10-K includes audited financial statements, business overview, risk factors, and management discussion, all available on SignalX with AI-generated summaries and XBRL financial data.

How do I view NGVT 10-Q quarterly reports?

Ingevity Corp (NGVT)'s most recent 10-Q quarterly report was filed on November 6, 2025. SignalX displays every NGVT 10-Q with AI-generated summaries of the MD&A (Management Discussion & Analysis) and Risk Factors sections, plus links to the original SEC EDGAR document.

What 8-K current reports has NGVT filed recently?

Ingevity Corp (NGVT)'s most recent 8-K was filed on April 15, 2026. 8-K filings disclose material corporate events such as earnings releases, executive changes, mergers, and other significant developments. SignalX surfaces each 8-K with item-level summaries so you can quickly see what happened.

Where can I find NGVT insider trading activity (Form 4)?

SignalX aggregates every NGVT Form 4 insider transaction from SEC EDGAR. Form 4 reports show when officers, directors, and 10% shareholders buy or sell company stock, with transaction code, share count, and price per share.

How often does NGVT file with the SEC?

Ingevity Corp (NGVT) files a 10-K annual report once per year (typically within 60 days of fiscal year-end) and 10-Q quarterly reports three times per year. 8-K current reports are filed as needed when material events occur, and Form 4 insider transaction reports are due within two business days of a trade. SignalX monitors SEC EDGAR daily to surface every new NGVT filing with AI-powered analysis.

What is the difference between 10-K, 10-Q, and 8-K SEC filings?

A 10-K is a comprehensive annual report with audited financials, business overview, and risk factors. A 10-Q is a shorter quarterly report with unaudited financials and management discussion. An 8-K is a current report filed when a material event occurs — such as earnings releases, executive changes, acquisitions, or other significant developments. SignalX provides AI-generated summaries for all three filing types for Ingevity Corp (NGVT).

What is NGVT's SEC CIK number?

Ingevity Corp (NGVT)'s SEC CIK (Central Index Key) number is 1653477. The CIK is a unique identifier assigned by the SEC to every filing entity. You can use CIK 1653477 to look up all NGVT filings on SEC EDGAR, or browse them here on SignalX with AI-powered analysis.

Where can I find NGVT return on equity (ROE) and financial data?

SignalX extracts XBRL financial data from Ingevity Corp (NGVT) 10-K annual filings, including revenue, net income, gross profit, operating income, EPS, total assets, stockholders' equity, and operating cash flow. Return on equity (ROE) can be derived from net income divided by stockholders' equity. Multi-year financial trends are displayed in the Financial Summary table above.

Stay on top of Ingevity Corp SEC filings

Insider trading data, fund holdings, cross-signal detection, and AI-powered analysis for 48+ filings.